Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
British Journal of Anaesthesia|May 1, 2012
Lidocaine time- and dose-dependently demethylates deoxyribonucleic acid in breast cancer cell lines in vitroP Lirk, R Berger, M W Hollmann, et al.
Methods of Information in Medicine|December 14, 2005
Gene methylation data--a new challenge for bioinformaticians?G Goebel, H M Müller, H Fiegl, et al.
British Journal of Pharmacology|July 31, 2014
Epigenetics in the perioperative periodP Lirk, H Fiegl, N C Weber, et al.
Cell Death and Differentiation|February 11, 2012
Mutual antagonism of TGF-beta and Interleukin-2 in cell survival and lineage commitment of induced regulatory T cellsD Tischner, G J Wiegers, H Fiegl, et al.
British Journal of Anaesthesia|June 21, 2014
Lidocaine and ropivacaine, but not bupivacaine, demethylate deoxyribonucleic acid in breast cancer cells in vitroP Lirk, M W Hollmann, M Fleischer, et al.
Oncogene|September 5, 2017
FOXO3-mediated chemo-protection in high-stage neuroblastoma depends on wild-type TP53 and SESN3M Rupp, J Hagenbuchner, B Rass, et al.
British Journal of Cancer|November 13, 2003
MeCP2 and MBD2 expression in human neoplastic and non-neoplastic breast tissue and its association with oestrogen receptor statusH M Müller, H Fiegl, G Goebel, et al.
Oncogene|April 26, 2011
Regulation of transcription factor E2F3a and its clinical relevance in ovarian cancerD Reimer, M Hubalek, H Kiefel, et al.
British Journal of Cancer|November 24, 2011
Elevated mRNA expression of CHAC1 splicing variants is associated with poor outcome for breast and ovarian cancer patientsG Goebel, R Berger, A M Strasak, et al.
Oncogene|January 27, 2010
Alternative splicing of p53 and p73: the novel p53 splice variant p53delta is an independent prognostic marker in ovarian cancerG Hofstetter, A Berger, H Fiegl, et al.
Pageof 2